Intrinsic Value of S&P & Nasdaq Contact Us

Aceragen, Inc. ACGN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ACGN

Aceragen, Inc. (ACGN) has a market capitalization of $3.24M and trades at $0.38. The 52-week range is 0.36-16.0.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-7.17, annual revenue of $4.86M.

The stock has a beta of 1.14, operates in the Healthcare sector.

Trading Data
Current Price$0.38
52-Week Range0.36-16.0
Volume52.51K
Avg Volume (30D)92.01K
Market Cap$3.24M
Beta (1Y)1.14
Company
IPO Date1996-01-25
Employees26
CEOJohn C. Taylor
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
Income (Latest Year)
Revenue$4.86M
Gross Profit$4.86M
EBITDA$-11.58M
Operating Income$-27.82M
Net Income$-23.36M
EPS$-7.17
EPS Diluted$-7.17
Shares Outstanding$3.26M
Balance Sheet (Latest Year)
Total Assets$101.11M
Current Assets$17.86M
Cash & ST Investments$12.04M
Total Liabilities$62.17M
Total Debt$560K
Net Debt$-11.48M
Total Equity$38.93M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-0.1
P/S Ratio0.67
P/B Ratio0.08
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message